Here are today's top news stories.
First, there's breast cancer research news about a potential new biomarker to evaluate whether a patient will benefit from tamoxifen. According to a study in the Journal of Clinical Oncology this week, women whose tumors expressed active Stat5 were more likely to benefit from tamoxifen. Larger trials are planned to confirm the findings.
In insurance news, the Oregon Senate approved a bill to expand insurance coverage for breast reconstruction after breast cancer surgery. Although insurers are currently required to cover reconstruction after mastectomy, a loophole permitted them to deny coverage for breast conserving surgeries or lumpectomies. The bill heads next to the governor's desk.
Finally, we just added an Exercise Guide for Breast Cancer Survivors to the site. Thanks to our Twitter friends for sharing resources!
As always, at LATESTBreastCancer.com, we welcome all comments, feedback and news tips!